Please wait while the formulary information is being retrieved.
MCCARNITINE (levocarnitine tartrate)
330 mg tablet
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Seizure disorder
MCCARNITINE (levocarnitine tartrate)
- None
- Abdominal pain with cramps
- Diarrhea
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- None
- Body odor
- Gastritis
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Bronchospastic pulmonary disease
- Laryngeal edema
- Muscle weakness
- Seizure disorder
Less Severe
- Facial edema
- Skin rash
- Urticaria
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
L-carnitine
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
L-carnitine
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool